Changing the Conversation on Adult Influenza Vaccination: Brazil
Brazil appears to have one of the highest influenza vaccination rates of older adults (98.2%) and those with chronic conditions (86.3%) in the world. Compliance of the target populations is largely attributable to the strong government-led influenza vaccination campaign which relies not only on remote communication but also on face-to-face mobilization.
The national campaign is highly organized and well-planned with clear target audiences, appropriate timelines, evidence-based information and the use of multiple communication tools. Campaign messages are widespread and visible in everyday life through websites, television, radio, newspapers, bus and subway panels. An enhanced and unique part of the Brazil’s campaign is a series of activities on the national mobilization day, including consultations and services across over 41,800 mobile vaccination spots.
By contrast, the campaign led by the civil society is relatively weak and underdeveloped. Only the Brazilian Society of Diabetes and the Brazilian Society of Immunizations have provided messages about influenza prevention and adult vaccination to their members and the general public.
Portuguese translation of the report and infographic are available below.
Campaign Overview: Brazil Report
View the report providing an overview of
the adult influenza campaign in Australia.
Brazil Resources

Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings.
The ‘Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care’ study was conducted to understand the status of existing public health policies and campaigns on pneumococcal disease in community and long-term care settings and its implications on the uptake of pneumococcal vaccination. The report highlights policy gaps for pneumococcal vaccination across long-term care settings in Canada and accordingly provides recommendations for policy improvements.
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings. Check out the technical report to learn more.